Thailand Pavilion at Expo 2025 Osaka Surpasses Two Million Visitors
At a glance
- The Thailand Pavilion opened on April 13, 2025, at Expo 2025 Osaka
- Over two million visitors attended during the 184-day event
- The pavilion highlighted Thai health innovations and traditional wisdom
The Thailand Pavilion at Expo 2025 Osaka, Kansai, Japan, operated from April 13 to October 13, 2025, and attracted a large number of visitors during its run. The pavilion served as a platform to present Thailand’s advancements in health and innovation to an international audience.
Presented under the theme “Thailand: Connecting Lives for Greatest Happiness,” the pavilion integrated elements of traditional health knowledge with modern technology. The Ministry of Public Health reported that the pavilion’s concept was designed to align with the Expo’s overarching theme, “Designing Future Society for Our Lives.”.
Throughout the event, the pavilion showcased a range of innovations, including the Dinsaw Mini AI healthcare assistant, Space Dynamic Prosthetic Foot, Titanium Cranioplasty Plates, and health products based on Thai herbal medicine. These exhibits aimed to reflect Thailand’s national identity through a blend of heritage and contemporary science.
Thai delegations also engaged with more than 100 international investors and partners during the Expo. Discussions focused on sectors such as digital health, electric vehicles, and the bio-circular-green economy, highlighting Thailand’s interest in expanding global collaborations.
What the numbers show
- The Thailand Pavilion reached 1.5 million visitors by September 2, 2025
- By October 5, 2025, visitor numbers had grown to approximately 1,981,922
- Over two million visitors attended by the Expo’s conclusion on October 13, 2025
The pavilion underwent a redesign during the Expo, which contributed to a steady increase in visitor numbers. By the 173rd day of the event, attendance had reached nearly two million, according to official reports.
Following the conclusion of Expo 2025 Osaka, the Ministry of Public Health confirmed that the pavilion welcomed over two million visitors during its 184-day operation. This figure reflects the sustained interest in the pavilion’s exhibits and activities throughout the event period.
Dr. Somlerk Juengsmarn, Permanent Secretary of the Ministry of Public Health, stated that the pavilion received consistently positive responses from visitors. The Ministry also highlighted the role of the pavilion in promoting Thailand’s leadership in health innovation and well-being on an international stage.
The Thailand Pavilion’s approach combined cultural heritage with technological progress, aiming to present a comprehensive view of the country’s contributions to health and wellness. Its participation at Expo 2025 Osaka provided opportunities for international engagement and showcased Thailand’s ongoing developments in related fields.
* This article is based on publicly available information at the time of writing.
Sources and further reading
- Grand Opening Ceremony of the Thailand Pavilion 2025 - THAILAND.GO.TH
- Ministry of Public Health Announces Thailand Pavilion’s
- Thailand to Showcase Medical and Wellness Excellence at Expo 2025 Osaka, Kansai, Japan
Note: This section is not provided in the feeds.
More on Health
-
Pieris Pharmaceuticals Completes Merger With Palvella Therapeutics
Pieris Pharmaceuticals and Palvella Therapeutics merged on December 13, 2024. Pieris will be delisted from Nasdaq, according to reports.
-
Reddit Highlights Human Content as AI Posts Rise on Platform
A Reddit survey reveals 53% of users prefer human content over AI. The platform plans to enhance verification to limit AI bot activity.
-
Measles Outbreak at Ave Maria University Becomes Largest on US Campus in Recent Years
More than 40 measles cases have been confirmed at Ave Maria University. Quarantine measures are in place for affected students, according to reports.
-
End Prescription Drug Ads Now Act Targets Consumer Marketing
A bill introduced on June 12, 2025, aims to ban direct-to-consumer prescription drug advertising in the U.S., according to Senate reports.